The makers of minimally invasive surgical devices seemed poised to capture a wide swath of the obesity treatment market. Patients needed an option that lay between the two treatment extremes: cutting open the abdomen to perform permanent bariatric surgery, or changing your diet or exercise routine.
Then, a new class of weight loss medications that successfully mimic the feeling of fullness hit the market, and the landscape changed.
Read the full article here.